Anthera Pharmaceuticals, Inc.
US ˙ OTCPK ˙ US03674U3005

Introduksjon

Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Brian Mueller. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.

Gjennomsnittlig handelslønnsomhet

Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,

Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.

Oppdateringsfrekvens: Daglig

Se listen over de mest lønnsomme insidetraderne.

Selskaper med rapporterte insiderposisjoner

SEC-arkiveringene indikerer at Brian Mueller har rapporterte beholdninger av handler i følgende selskaper:

Verdipapir Navn Siste rapporterte høydepunkter
US:BMRN / BioMarin Pharmaceutical Inc. EVP, Chief Financial Officer 99 781
US:ANTH / Anthera Pharmaceuticals, Inc. Director 84 705
Hvordan tolke diagrammene

De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Brian Mueller. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.

Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.

Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.

Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.

Internkjøp ANTH / Anthera Pharmaceuticals, Inc. - Analyse av kortsiktig fortjeneste

I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i ANTH / Anthera Pharmaceuticals, Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.

Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.

Handelsdato Ticker Innsider Rapporterte
aksjer
Rapportert
pris
Justerte
aksjer
Justert
pris
Kostpris Dager til
maks
Pris ved
maks
Maks
fortjeneste ($)
Maks fortjeneste (%)
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen.

Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.

ANTH / Anthera Pharmaceuticals, Inc. Insider Trades
Internhandel ANTH / Anthera Pharmaceuticals, Inc. - Analyse av kortsiktig tap

I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i ANTH / Anthera Pharmaceuticals, Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.

Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.

Handelsdato Ticker Innsider Rapporterte
aksjer
Rapportert
pris
Justerte
aksjer
Justert
pris
Kostpris Dager til
min
Pris ved
min
Maks tap
unngått ($)
Maks tap
unngått (%)
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen.

Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.

ANTH / Anthera Pharmaceuticals, Inc. Insider Trades
Innsidernes handelshistorikk

Tabellen viser den komplette listen over innsidehandler gjort av Brian Mueller som avslørt til Securies Exchange Comission (SEC).

Fildato Transaksjonsdato Skjema Ticker Verdipapir Kode 10b5-1 Aksjer Gjenværende aksjer Prosent
endring
Aksje
pris
Transaksjons
verdi
Gjenværende
verdi
2025-03-18 2025-03-17 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 16 640 99 781 20,01
2025-03-18 2025-03-14 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −18 497 83 141 −18,20 69,44 −1 284 432 5 773 311
2025-02-27 2025-02-25 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 9 367 101 638 10,15
2025-02-27 2025-02-25 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 9 660 92 271 11,69
2025-02-27 2025-02-25 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 11 040 82 611 15,43
2024-07-01 2024-06-28 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −588 71 571 −0,81 82,33 −48 410 5 892 440
2024-05-31 2024-05-30 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X −5 000 72 159 −6,48 75,19 −375 950 5 425 635
2024-05-31 2024-05-30 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 5 000 77 159 6,93 63,10 315 500 4 868 733
2024-05-31 2024-04-30 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 300 72 159 0,42 68,65 20 594 4 953 427
2024-03-19 2024-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −20 789 71 859 −22,44 83,87 −1 743 573 6 026 814
2024-03-19 2024-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 11 400 92 648 14,03
2024-02-29 2024-02-27 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 6 103 81 248 8,12
2024-02-29 2024-02-27 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 8 802 75 145 13,27
2024-02-29 2024-02-27 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 20 220 66 343 43,84
2024-02-12 2023-04-28 5 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 318 46 123 0,69 66,88 21 267 3 084 614
2023-06-30 2023-06-29 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −576 45 805 −1,24 88,93 −51 224 4 073 439
2023-06-30 2023-06-29 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −4 602 46 381 −9,03 88,93 −409 256 4 124 662
2023-06-30 2023-06-29 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −4 602 46 381 −9,03 88,93 −409 256 4 124 662
2023-03-17 2023-03-16 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −3 973 55 585 −6,67 93,41 −371 118 5 192 195
2023-03-17 2023-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −2 708 59 558 −4,35 87,74 −237 600 5 225 619
2023-03-17 2023-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 9 630 62 266 18,30
2023-03-02 2023-02-28 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 1 250 52 636 2,43
2023-03-02 2023-02-28 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 10 980 51 386 27,17
2023-03-02 2023-02-28 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 12 660 40 406 45,63
2023-01-17 2023-01-13 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X −2 500 27 746 −8,27 114,50 −286 250 3 176 917
2023-01-17 2023-01-13 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 2 500 30 246 9,01 63,10 157 750 1 908 523
2022-12-15 2022-12-13 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X −2 500 27 746 −8,27 107,50 −268 750 2 982 695
2022-12-15 2022-12-13 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 2 500 30 246 9,01 63,10 157 750 1 908 523
2022-12-06 2022-12-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X −3 761 27 746 −11,94 104,50 −393 024 2 899 457
2022-12-06 2022-12-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 3 761 31 507 13,56 67,81 255 033 2 136 490
2022-12-06 2022-12-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X −2 139 27 746 −7,16 104,50 −223 526 2 899 457
2022-12-06 2022-12-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 2 139 29 885 7,71 67,81 145 046 2 026 502
2022-12-06 2022-12-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X −1 101 27 746 −3,82 104,50 −115 054 2 899 457
2022-11-28 2022-11-23 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X −3 500 28 847 −10,82 99,50 −348 250 2 870 276
2022-11-28 2022-11-23 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 3 500 32 347 12,13 67,81 237 335 2 193 450
2022-11-28 2022-11-23 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X −945 28 847 −3,17 99,50 −94 028 2 870 276
2022-11-28 2022-11-23 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X −934 29 792 −3,04 95,09 −88 814 2 832 921
2022-08-09 2022-08-05 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X −3 500 30 726 −10,23 94,50 −330 750 2 903 607
2022-08-09 2022-08-05 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 3 500 34 226 11,39 67,81 237 335 2 320 865
2022-07-12 2022-07-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X −7 337 30 726 −19,28 89,50 −656 662 2 749 977
2022-07-01 2022-06-29 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −576 38 063 −1,49 83,92 −48 338 3 194 247
2022-05-06 2022-05-04 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock)
M - Exercise X −9 762 0 −100,00
2022-05-06 2022-05-04 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock)
M - Exercise X −2 038 0 −100,00
2022-05-06 2022-05-04 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X −9 762 38 639 −20,17 84,50 −824 889 3 264 996
2022-05-06 2022-05-04 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 9 762 48 401 25,26 37,46 365 685 1 813 101
2022-05-06 2022-05-04 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X −2 038 38 639 −5,01 84,50 −172 211 3 264 996
2022-05-06 2022-05-04 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 2 038 40 677 5,27 37,46 76 343 1 523 760
2022-05-06 2022-04-29 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 340 38 639 0,89 62,41 21 218 2 411 344
2022-03-17 2022-03-16 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −582 38 299 −1,50 80,72 −46 979 3 091 495
2022-03-17 2022-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock)
A - Award 26 520 26 520
2022-03-17 2022-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −1 868 38 881 −4,58 78,27 −146 208 3 043 216
2022-03-17 2022-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 11 040 40 749 37,16
2022-02-07 2022-02-03 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −1 072 29 709 −3,48 87,77 −94 089 2 607 559
2021-06-30 2021-06-29 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −576 30 781 −1,84 83,46 −48 073 2 568 982
2021-05-11 2021-05-07 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock)
M - Exercise X −6 709 0 −100,00
2021-05-11 2021-05-07 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X −6 709 31 357 −17,62 79,50 −533 366 2 492 882
2021-05-11 2021-05-07 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 6 709 38 066 21,40 28,23 189 395 1 074 603
2021-05-11 2021-04-30 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 341 31 357 1,10 62,41 21 281 1 956 896
2021-04-02 2021-04-01 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X −5 692 31 016 −15,51 76,30 −434 300 2 366 521
2021-03-23 2021-03-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −516 36 708 −1,39 78,52 −40 516 2 882 312
2021-03-17 2021-03-16 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −582 37 224 −1,54 77,21 −44 936 2 874 065
2021-03-17 2021-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock)
A - Award 24 890 24 890
2021-03-17 2021-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −994 37 806 −2,56 78,39 −77 920 2 963 612
2021-03-17 2021-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 10 110 38 800 35,24
2021-02-12 2020-10-30 5 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 17 29 761 0,06 62,59 1 064 1 862 622
2021-02-04 2021-02-03 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −1 071 28 673 −3,60 82,82 −88 700 2 374 698
2020-06-30 2020-06-29 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock)
A - Award 13 230 13 230
2020-06-30 2020-06-29 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4 640 29 744 18,48
2020-06-30 2020-04-30 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 323 25 104 1,30 62,59 20 215 1 571 159
2020-03-24 2020-03-20 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −414 24 781 −1,64 73,05 −30 243 1 810 252
2020-03-17 2020-03-16 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock)
A - Award 9 600 9 600
2020-03-17 2020-03-16 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 6 730 25 195 36,45
2020-03-17 2020-03-13 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −1 303 18 465 −6,59 84,50 −110 104 1 560 292
2020-02-04 2020-02-03 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 5 800 19 768 41,52
2020-02-04 2019-10-31 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 9 13 968 0,06 62,23 560 869 215
2019-06-07 2019-04-30 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 299 13 959 2,19 68,78 20 566 960 128
2019-04-09 2019-04-05 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X −2 953 13 660 −17,78 94,00 −277 582 1 284 040
2019-03-26 2019-03-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −415 16 613 −2,44 88,05 −36 541 1 462 775
2019-03-19 2019-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock)
A - Award 9 650 9 650
2019-03-19 2019-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 5 780 17 028 51,39
2019-03-19 2019-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −1 149 11 248 −9,27 94,53 −108 615 1 063 273
2018-12-20 2018-10-31 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 22 12 397 0,18 68,78 1 513 852 690
2018-08-09 2018-08-07 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock)
M - Exercise X −782 6 709 −10,44
2018-08-09 2018-08-07 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock)
M - Exercise X −1 718 0 −100,00
2018-08-09 2018-08-07 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X −2 500 12 375 −16,81 104,50 −261 250 1 293 188
2018-08-09 2018-08-07 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 782 14 875 5,55 28,23 22 076 419 921
2018-08-09 2018-08-07 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 1 718 14 093 13,88 28,23 48 499 397 845
2018-06-26 2018-06-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock)
M - Exercise X −2 491 1 718 −59,18
2018-06-26 2018-06-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X −2 491 12 375 −16,76 99,50 −247 854 1 231 312
2018-06-26 2018-06-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 2 491 14 866 20,13 28,23 70 321 419 667
2018-06-26 2018-06-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X −654 12 375 −5,02 99,50 −65 073 1 231 312
2018-06-18 2018-06-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X −2 021 13 029 −13,43 94,50 −190 984 1 231 240
2018-06-06 2018-06-04 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −346 15 050 −2,25 92,07 −31 856 1 385 654
2018-05-14 2018-05-10 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X −2 450 15 396 −13,73 89,50 −219 275 1 377 942
2018-05-14 2018-04-30 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 287 17 846 1,63 68,78 19 740 1 227 484
2018-03-26 2018-03-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −414 17 559 −2,30 81,36 −33 683 1 428 600
2018-03-20 2018-03-16 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −346 12 263 −2,74 84,10 −29 099 1 031 318
2018-03-20 2018-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock)
A - Award 9 120 9 120
2018-03-20 2018-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 5 710 17 973 46,56
2018-03-20 2018-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −309 12 609 −2,39 83,57 −25 823 1 053 734
2018-02-14 2017-10-31 5 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 33 12 918 0,26 69,78 2 303 901 379
2018-01-09 2018-01-05 4 ANTH Anthera Pharmaceuticals Inc
Stock Option (right to buy)
A - Award 84 705 84 705
2018-01-09 2018-01-05 4 ANTH Anthera Pharmaceuticals Inc
Stock Option (right to buy)
A - Award 84 705 84 705
2017-06-23 2017-06-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock)
M - Exercise X −2 671 0 −100,00
2017-06-23 2017-06-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X −2 671 12 885 −17,17 100,00 −267 100 1 288 500
2017-06-23 2017-06-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 2 671 15 556 20,73 21,51 57 453 334 610
2017-06-06 2017-06-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −376 12 885 −2,84 90,72 −34 111 1 168 927
2017-05-17 2017-05-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −207 13 261 −1,54 91,50 −18 940 1 213 382
2017-05-10 2017-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock)
M - Exercise X −2 600 2 671 −49,33
2017-05-10 2017-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X −2 600 13 468 −16,18 93,17 −242 242 1 254 814
2017-05-10 2017-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 2 600 16 068 19,31 21,51 55 926 345 623
2017-05-10 2017-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X −4 882 13 468 −26,60 91,17 −445 092 1 227 878
2017-05-10 2017-04-28 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 270 18 350 1,49 70,30 18 982 1 290 078
2017-03-24 2017-03-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock)
A - Award 7 740 7 740
2017-03-24 2017-03-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4 790 18 080 36,04
2017-03-17 2017-03-16 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −376 13 290 −2,75 90,96 −34 201 1 208 858
2017-03-17 2017-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −336 13 666 −2,40 92,50 −31 080 1 264 105
2017-02-14 2016-10-31 5 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 62 14 002 0,44 68,42 4 242 958 045
2016-08-03 2016-08-01 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X −287 14 260 −1,97 100,00 −28 700 1 426 000
2016-06-07 2016-06-03 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −376 14 547 −2,52 90,00 −33 840 1 309 230
2016-05-17 2016-05-13 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −207 14 923 −1,37 82,71 −17 121 1 234 281
2016-05-10 2016-05-06 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −444 15 130 −2,85 80,80 −35 875 1 222 504
2016-05-10 2016-04-29 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 327 15 574 2,14 51,26 16 763 798 386
2016-04-29 2016-04-27 4 ANTH Anthera Pharmaceuticals Inc
Stock Option (right to buy)
A - Award 41 379 41 379
2016-03-17 2016-03-16 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −376 15 247 −2,41 80,34 −30 208 1 224 944
2016-03-17 2016-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy) Common Stock
A - Award 7 000 7 000
2016-03-17 2016-03-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 3 570 15 623 29,62
2016-02-12 2015-10-31 5 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 127 12 053 1,06 51,26 6 510 617 879
2015-12-24 2015-12-23 4 ANTH Anthera Pharmaceuticals Inc
Common stock
M - Exercise 10 000 10 000 2,89 28 900 28 900
2015-12-24 2014-07-29 4 ANTH Anthera Pharmaceuticals Inc
Stock Option (right to buy)
M - Exercise −10 000 2 500 −80,00
2015-06-08 2015-06-04 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −522 11 926 −4,19 120,46 −62 880 1 436 606
2015-06-03 2015-05-31 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −308 12 448 −2,41 125,57 −38 676 1 563 095
2015-05-22 2015-05-21 4 ANTH Anthera Pharmaceuticals Inc
Stock Option (right to buy)
A - Award 28 846 28 846
2015-05-19 2015-05-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −207 12 756 −1,60 122,78 −25 415 1 566 182
2015-05-12 2015-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −444 12 963 −3,31 121,66 −54 017 1 577 079
2015-05-12 2015-04-30 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 607 13 407 4,74 51,26 31 117 687 290
2015-03-17 2015-03-16 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
A - Award 9 000 9 000
2015-03-17 2015-03-16 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4 000 12 800 45,45
2015-03-05 2014-06-04 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
A - Award 10 000 10 000
2015-03-05 2014-06-04 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4 000 8 800 83,33
2015-03-05 2015-03-03 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale −7 000 8 800 −44,30 109,46 −766 210 963 235
2015-03-05 2015-03-03 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 7 000 15 800 79,55 28,23 197 610 446 034
2015-03-05 2014-12-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy Common Stock)
M - Exercise −7 000 7 491 −48,31
2015-01-02 2014-12-30 4 ANTH Anthera Pharmaceuticals Inc
Stock Option (right to buy)
A - Award 12 500 12 500
2014-12-03 2014-12-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy Common Stock)
M - Exercise −5 000 14 491 −25,65
2014-12-03 2014-12-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale −5 000 4 593 −52,12 91,82 −459 100 421 729
2014-12-03 2014-12-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 5 000 9 593 108,86 28,23 141 150 270 810
2014-12-03 2014-12-01 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy Common Stock)
M - Exercise −6 429 0 −100,00
2014-12-03 2014-12-01 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy Common Stock)
M - Exercise −521 0 −100,00
2014-12-03 2014-12-01 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale −6 950 4 593 −60,21 90,25 −627 238 414 518
2014-12-03 2014-12-01 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 6 429 11 543 125,71 21,51 138 288 248 290
2014-12-03 2014-12-01 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 521 5 114 11,34 14,39 7 497 73 590
2014-12-02 2014-11-26 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale −3 400 4 593 −42,54 88,97 −302 508 408 653
2014-08-04 2014-07-29 4 ANTH Anthera Pharmaceuticals Inc
Stock Option (right to buy)
A - Award 12 500 12 500
2014-08-04 2014-07-29 4 ANTH Anthera Pharmaceuticals Inc
Stock Option (right to buy)
A - Award 18 750 18 750
2014-06-03 2014-05-31 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −297 7 993 −3,58 57,96 −17 214 463 274
2014-05-16 2014-05-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −207 8 290 −2,44 57,44 −11 890 476 178
2014-05-14 2014-05-12 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −282 8 497 −3,21 59,30 −16 723 503 872
2014-05-12 2014-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −444 8 281 −5,09 56,78 −25 210 470 195
2014-05-12 2014-04-30 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 498 8 779 6,01 29,69 14 786 260 649
2014-02-13 2013-10-31 5 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 278 8 725 3,29 27,91 7 758 243 475
2013-06-04 2013-05-31 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −413 8 447 −4,66 62,70 −25 895 529 627
2013-05-17 2013-05-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
A - Award 12 900 12 900
2013-05-17 2013-05-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 2 200 8 860 33,03
2013-05-15 2013-05-14 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise −3 500 6 429 −35,25 21,51 −75 285 138 288
2013-05-15 2013-05-14 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale −3 500 6 660 −34,45 70,33 −246 155 468 398
2013-05-15 2013-05-14 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 3 500 10 160 52,55 21,51 75 285 218 542
2013-05-15 2013-05-14 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale −1 447 6 660 −17,85 70,41 −101 890 468 961
2013-05-14 2013-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −479 8 924 −5,09 65,32 −31 288 582 916
2013-05-14 2013-05-12 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −817 8 107 −9,16 67,68 −55 295 548 682
2013-05-06 2013-05-03 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
M - Exercise −4 874 521 −90,34
2013-05-06 2013-05-03 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale −7 500 9 403 −44,37 67,11 −503 295 630 998
2013-05-06 2013-05-03 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 7 500 16 903 79,76 21,51 161 325 363 584
2013-05-06 2013-05-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
M - Exercise −7 500 15 200 −33,04
2013-05-06 2013-05-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale −4 457 9 403 −32,16 65,48 −291 858 615 737
2013-05-06 2013-05-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale −4 874 13 860 −26,02 65,35 −318 496 905 696
2013-05-06 2013-05-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 4 874 18 734 35,17 14,39 70 137 269 582
2013-05-06 2013-04-30 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 581 13 860 4,38 23,20 13 482 321 621
2013-03-04 2013-03-01 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
M - Exercise −3 605 63 595 −5,36
2013-03-04 2013-03-01 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
M - Exercise −730 67 200 −1,07
2013-03-04 2013-03-01 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
M - Exercise −688 67 930 −1,00
2013-03-04 2013-03-01 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale 2 015 13 279 17,89 59,81 120 510 794 171
2013-03-04 2013-03-01 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale −5 023 15 294 −24,72 59,74 −300 067 913 642
2013-03-04 2013-03-01 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 3 605 20 317 21,57 14,39 51 876 292 362
2013-03-04 2013-03-01 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 730 16 712 4,57 17,86 13 038 298 476
2013-03-04 2013-03-01 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 688 15 982 4,50 38,59 26 550 616 745
2013-02-14 2012-10-31 5 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
P - Purchase 548 15 294 3,72 21,76 11 924 332 797
2013-02-14 2012-05-31 5 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −290 14 746 −1,93 35,64 −10 336 525 547
2013-02-14 2012-05-12 5 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −574 15 036 −3,68 38,00 −21 812 571 368
2012-11-19 2012-11-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
M - Exercise X −10 312 68 618 −13,06
2012-11-19 2012-11-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
M - Exercise X −5 500 78 930 −6,51
2012-11-19 2012-11-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X −15 812 15 340 −50,76 50,00 −790 600 767 000
2012-11-19 2012-11-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 10 312 31 152 49,48 38,59 397 940 1 202 156
2012-11-19 2012-11-15 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 5 500 20 840 35,85 14,39 79 145 299 888
2012-11-07 2012-11-05 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
M - Exercise X −8 000 84 430 −8,66
2012-11-07 2012-11-05 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X −5 500 15 340 −26,39 47,50 −261 250 728 650
2012-11-07 2012-11-05 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X −2 500 20 840 −10,71 46,00 −115 000 958 640
2012-11-07 2012-11-05 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 8 000 23 340 52,15 14,39 115 120 335 863
2012-07-11 2012-07-10 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
M - Exercise X −2 500 92 430 −2,63
2012-07-11 2012-07-10 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X −2 500 15 340 −14,01 42,50 −106 250 651 950
2012-07-11 2012-07-10 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 2 500 17 840 16,30 14,39 35 975 256 718
2012-07-05 2012-07-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock
M - Exercise X −2 770 94 930 −2,84
2012-07-05 2012-07-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale X −2 770 15 340 −15,30 40,00 −110 800 613 600
2012-07-05 2012-07-02 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise X 2 770 18 110 18,06 17,86 49 472 323 445
2012-05-23 2012-05-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Restricted Stock Units
M - Exercise 150 2 462 6,49
2012-05-23 2012-05-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
F - Taxes −56 15 340 −0,36 37,98 −2 127 582 613
2012-05-23 2012-05-22 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 150 15 396 0,98
2012-05-14 2012-05-12 4 BMRN BIOMARIN PHARMACEUTICAL INC
Restricted Stock Units
M - Exercise 750 2 612 40,28
2012-05-14 2012-05-12 4 BMRN BIOMARIN PHARMACEUTICAL INC
Restricted Stock Units
M - Exercise 812 3 362 31,84
2012-05-14 2012-05-12 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 750 15 246 5,17
2012-05-14 2012-05-12 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 812 14 496 5,93
2012-05-11 2012-05-08 4/A BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy)
M - Exercise −375 97 700 −0,38
2012-05-11 2012-05-08 4/A BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy)
M - Exercise −625 98 075 −0,63 37,50 −23 438 3 677 812
2012-05-11 2012-05-08 4/A BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy)
M - Exercise −4 291 98 700 −4,17
2012-05-11 2012-05-08 4/A BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy)
M - Exercise −417 102 991 −0,40
2012-05-11 2012-05-08 4/A BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy)
M - Exercise −10 000 103 408 −8,82
2012-05-11 2012-05-08 4/A BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy)
A - Award 11 800 113 408 11,61
2012-05-11 2012-05-08 4/A BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale −15 708 13 684 −53,44 37,50 −589 050 513 150
2012-05-11 2012-05-08 4/A BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 375 29 392 1,29 17,89 6 709 525 823
2012-05-11 2012-05-08 4/A BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 625 29 017 2,20 17,89 11 181 519 114
2012-05-11 2012-05-08 4/A BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 4 291 28 392 17,80 17,33 74 363 492 033
2012-05-11 2012-05-08 4/A BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 417 24 101 1,76 17,54 7 314 422 732
2012-05-11 2012-05-08 4/A BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 10 000 23 684 73,08 11,74 117 400 278 050
2012-05-11 2012-05-08 4/A BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4 720 13 684 52,66
2012-05-11 2012-04-30 4/A BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 664 8 964 8,00 19,35 12 846 173 418
2012-05-10 2012-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy)
M - Exercise −375 97 650 −0,38
2012-05-10 2012-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy)
M - Exercise −675 98 025 −0,68 37,50 −25 312 3 675 938
2012-05-10 2012-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy)
M - Exercise −4 291 98 700 −4,17
2012-05-10 2012-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy)
M - Exercise −417 102 991 −0,40
2012-05-10 2012-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy)
M - Exercise −10 000 103 408 −8,82
2012-05-10 2012-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy)
A - Award 11 800 113 408 11,61
2012-05-10 2012-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale −15 708 13 684 −53,44 37,50 −589 050 513 150
2012-05-10 2012-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 375 29 392 1,29 17,89 6 709 525 823
2012-05-10 2012-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 625 29 017 2,20 17,89 11 181 519 114
2012-05-10 2012-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 4 291 28 392 17,80 17,33 74 363 492 033
2012-05-10 2012-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 417 24 101 1,76 17,54 7 314 422 732
2012-05-10 2012-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 10 000 23 684 73,08 11,74 117 400 278 050
2012-05-10 2012-05-08 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 4 720 13 684 52,66
2012-05-10 2012-04-30 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
A - Award 664 8 964 8,00 19,35 12 846 173 418
2012-02-28 2012-02-24 4 BMRN BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy)
M - Exercise −5 000 101 608 −4,69
2012-02-28 2012-02-24 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
S - Sale −5 000 8 300 −37,59 35,06 −175 325 291 040
2012-02-28 2012-02-24 4 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
M - Exercise 5 000 13 300 60,24 11,74 58 700 156 142
2012-02-14 2011-10-31 5 BMRN BIOMARIN PHARMACEUTICAL INC
Common Stock
P - Purchase 964 8 300 13,14 13,23 12 750 109 776
P
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
S
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
A
Bevilgning, tildeling eller andre oppkjøp av verdipapirer fra selskapet (slik som en opsjon)
C
Konvertering av derivat
D
Salg eller overføring av verdipapirer tilbake til selskapet
F
Betaling av utøvelseskurs eller skatteplikt ved å bruke deler av verdipapirer mottat fra selskapet
G
Gave av verdipapirer fra eller til insidere
K
Aksjebytting og lignende sikringsavtaler
M
Øvelse eller konvertering av derivatverdipapir mottatt fra selskapet (for eksempel en opsjon)
V
En transaksjon frivilig rapportert på Skjema 4
J
Annet (med en fotnote som beskriver transaksjonen)